U.S. markets close in 1 hour 50 minutes
  • S&P 500

    3,839.83
    -30.46 (-0.79%)
     
  • Dow 30

    31,419.12
    +27.60 (+0.09%)
     
  • Nasdaq

    13,059.86
    -298.93 (-2.24%)
     
  • Russell 2000

    2,233.31
    +1.80 (+0.08%)
     
  • Crude Oil

    61.54
    +1.79 (+3.00%)
     
  • Gold

    1,717.50
    -16.10 (-0.93%)
     
  • Silver

    26.34
    -0.53 (-1.99%)
     
  • EUR/USD

    1.2073
    -0.0015 (-0.12%)
     
  • 10-Yr Bond

    1.4700
    +0.0550 (+3.89%)
     
  • GBP/USD

    1.3966
    +0.0010 (+0.07%)
     
  • USD/JPY

    106.9840
    +0.2740 (+0.26%)
     
  • BTC-USD

    51,103.94
    +3,248.48 (+6.79%)
     
  • CMC Crypto 200

    1,023.74
    +35.64 (+3.61%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

ENDP ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 18, 2020 in the Class Action Filed on Behalf of Endo International Plc Limited Shareholders

  • Oops!
    Something went wrong.
    Please try again later.
Newsfile Corp.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

New York, New York--(Newsfile Corp. - August 14, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Endo International Plc (NASDAQ: ENDP) alleging that the Company violated federal securities laws.

Class Period: August 8, 2017 and June 10, 2020
Lead Plaintiff Deadline: August 18, 2020

Learn more about your recoverable losses in DNK:
http://www.kleinstocklaw.com/pslra-1/endo-international-plc-loss-submission-form?id=8588&from=5

The filed complaint alleges that Endo International Plc made materially false and/or misleading statements and/or failed to disclose that: (i) Endo's and/or its subsidiaries' contributions to the opioid crisis (including, but not limited to, their opioid products' disproportionately negative impact on New York and the fraud that Defendants perpetrated on the New York insurance market) were larger in scope than the Company had represented; (ii) part of that contribution to the crisis included Endo publishing and disseminating false information to health care providers regarding the risks and benefits of opioids; (iii) the foregoing, once revealed, was foreseeably likely to subject Endo and/or its subsidiaries to increased regulatory scrutiny and enforcement, as well as significant financial and/or reputational harm, particularly with respect to New York; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders have until August 18, 2020 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

For additional information about the ENDP lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click the link above.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/61766